Sympathetic Innervation of the Heart and Cardiac Resynchronization Therapy(CRT)
| Conditions | Phase | Intervention Type |
|---|---|---|
| N/A |
Eligibility
- Ages Eligible for Study
- 18 years to 85 years
- Genders Eligible for Study
- Both
Keywords
Sponsors
- Other
- University Medical Centre Groningen
Inclusion Criteria
- Indication for CRT
- Stable optimal medication
- Non ischemic cardiomyopathy
Exclusion Criteria
- Age less then 18 years
- Previous CRT
- Clinically relevant valvular heart disease or coronary artery disease
- Acute or chronic infection
- Untreated clinical hypo- or hyperthyroidism or < 3 months euthyroidism
- Uncontrolled hypertension, defined as a systolic blood pressure > 160 mm Hg and/or a
diastolic blood pressure > 95 mm Hg
- A concurrent medical condition (i.e. alcohol or drug abuse or a severe progressive
extra cardiac disease or M. Parkinson) or is unlikely to comply with the protocol
- Participation to a previous protocol involving radioactivity in the past year
- Pregnancy
Detailed Description
The purpose of this study is to assess whether baseline sympathetic innervation in patients with chronic heart failure (CHF) is predictive for response to cardiac resynchronization therapy (CRT). And to assess whether response to CRT coincides with restoration of regional sympathetic innervation.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00567645
Overall Contact Backup
Locations
-
University Medical Center GroningenGroningen, Netherlands(Recruiting)
Contact info
I.C. van Gelder , Prof050-3612355i.c.van.Gelder@thorax.umcg.nl